Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

SELLAS Life Sciences Group Inc buy El_Zocko

SELLAS Life Sciences Group Inc
Start price
€45,810
27.02.15 / 50%
Target price
€55,500
06.03.15
Performance (%)
26.39%
End price
€57,900
06.03.15
Summary
This prediction ended on 06.03.15 with a price of €57,900. The prediction had a final performance of 26.39%. El_Zocko has 50% into this prediction

SELLAS Life Sciences is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, is a cancer immunotherapy being developed for the treatment of acute myeloid leukemia (AML) and ovarian cancer. SELLAS Life Sciences is listed on the NASDAQ stock exchange under the symbol RXII.

AI-generated
Performance without dividends (%)
Name 1w 1m 1y 3y
SELLAS Life Sciences Group Inc 6.250% 6.250% 727.096% 684.801%
iShares Core DAX® 0,44 % 5,64 % 7,81 % 63,64 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 % 88,12 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 % 83,53 %
iShares S&P 500 0,37 % 1,92 % 22,34 % 68,75 %

Comments by El_Zocko for this prediction

In the thread SELLAS Life Sciences Group Inc diskutieren
Prediction Buy
Perf. (%) 26.39%
Target price 1110.000
Change
Ends at 06.03.15

GALENA BIOPHARMA

Trendwende geschafft? Ich sage: ja!

El_Zocko 
0
Report Share
27.02.15
Prediction Buy
Perf. (%) 26.39%
Target price 1110.000
Change
Ends at 06.03.15

(Zielkurs erreicht)

El_Zocko 
0
Report Share
06.03.15